Tiziana Life Sciences (TLSA) Income Statement: Revenue & Earnings

Tiziana Life Sciences Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Tiziana Life Sciences Ltd income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	0.00	0.00	0.00	-13.31	0.00
Cost of Revenue	0.00	0.00	0.00	0.00	0.00
Gross Profit	0.00	0.00	0.00	-13.31	0.00
Operating Expenses
Research & Development	5.23	8.11	12.96	13.21	5.99
Selling, General & Administrative	0.00	9.87	1.63	0.86	-2.66
Operating Expenses	15.79	17.98	14.59	13.17	19.21
Operating Income	-15.79	-17.98	-14.59	-26.48	-19.21
Other Income/Expense
Interest Income	0.81	1.15	0.03	0.00	0.01
Interest Expense	0.01	0.01	-0.01	0.18	-0.32
Other Income/Expense	-0.95	-0.40	0.03	4.48	8.54
Income
Income Before Tax	-16.75	-17.24	-15.40	-31.14	-24.86
Income Tax Expense	-4.88	0.45	0.00	-3.24	-2.21
Net Income	-11.86	-17.69	-15.40	-27.90	-22.66
Net Income - Continuous Operations	-11.86	-17.69	-15.40	-23.42	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	-16.62	-17.14	-14.59	-31.13	-24.86
EBIT	-16.74	-17.23	-14.59	-31.14	-24.86
Depreciation & Amortization	0.12	0.10	0.00	-0.13	-0.09
Earnings Per Share
Basic EPS	-	-	-	-	-15.00
Diluted EPS	-	-	-	-	-15.00
Basic Shares Outstanding	53.34	102.47	101.53	97.93	169.07
Diluted Shares Outstanding	53.34	102.47	101.53	97.93	169.07